Verily welcomes new organizations who will use Workbench to manage large biomedical datasets and accelerate research

Dallas, TX – April 17, 2025 – Verily, an Alphabet health technology company, today announced  the addition of several new institutions using Workbench to manage their large biomedical datasets, as it introduces new features.

Verily launched Workbench in 2023 as a scalable research environment used to unify multimodal data and accelerate biomedical research. Workbench is powered by the Verily platform, which securely organizes complex healthcare data and provides the tools to enable users to safely and easily collaborate and analyze unified datasets to advance research and discovery. 

Verily has recently added a number of new customers using Workbench, spanning industry, academia, and government agencies, including:

• NashBio will implement Workbench to enable their customers to explore and analyze clinical, genomics, and medical imaging data. 
• University of Oxford will use Workbench to support an academic-industry collaboration that aims to develop disease agnostic platforms to change the clinical practice of pathology, helping to identify and validate early potential drug targets, and biomarkers to predict disease progression. 
• NIH Intramural Center for Alzheimer's and Related Dementias (CARD) will use Workbench to set standards for data and code used in harmonizing and analyzing digital pathology plus clinical and omics data at scale, to increase efficiency while ensuring AI-readiness.

In addition, the Foundation for the National Institutes of Health (FNIH) recently welcomed Verily to AMP Parkinson's Disease and Related Disorders (AMP PDRD) as a private-sector partner. AMP PDRD will soon implement Workbench, enabling researchers to access global multimodal datasets to drive clinical and molecular characterization of patients with Parkinson’s disease and other related disorders.

“Verily’s Workbench will help NashBio govern its vast collection of clinical, genomic, and medical imaging data, providing researchers with streamlined access to these data in order to power precision medicine research,” said Leeland Ekstrom, PhD, chief executive officer of NashBio. “This technology aligns well with our mission to make complex healthcare data easier to use and will speed time to insight for our researcher and innovator customers.”

Workbench has added new features and functionality that make it easier to manage, access, and analyze data. Workbench now offers a broader suite of analysis, coding, and workflow tools, such as Visual Studio, JupyterLab with Spark clusters, and WDL workflows, in addition to existing tools such as RAnalysis, GitHub, and BigQuery. New governance capabilities allow users to enforce Workspace policies on a wider range of cloud APIs, including Vertex AI and Dataflow.

Workbench will soon launch a new Discover feature that enables researchers to browse a catalog of public and enterprise data. The page will help customers securely improve data access and reuse, while giving users the ability to find new datasets to support their research needs. This will serve as the foundation for a broader Verily data ecosystem that will feature a variety of unique third party and proprietary datasets in order to increase their reach and impact, powered by Verily’s curation and enrichment capabilities, along with other platform tools.

“Verily is committed to helping organizations make complex biomedical data more accessible, discoverable, and easier to analyze in order to accelerate research and improve care,” said Myoung Cha, chief product officer at Verily. “Through the Verily platform, and our Workbench solution, we are providing the scalable infrastructure needed to effectively store, share, and analyze data in a safe and secure way, while expanding the use of these data by the research community.”

Biomedical data is growing at an exponential rate, fueled by developments in AI, genomics, and personalized medicine. The vast majority of this data is underutilized because of challenges around governance, data management, and scalable analysis. Verily’s Workbench helps organizations put data to work by providing a secure and collaborative environment to govern and enable analysis of their data.

About Verily
Verily is an Alphabet data platform and technology company purpose-built to power AI for precision health. Verily offers AI-enabled solutions that transform disparate health data into insights and actions that accelerate research and improve care for individuals and communities. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools that accelerate evidence generation, enable more personalized care, and help manage disease at a population level. For more information about Verily please visit: verily.com.